Patents by Inventor Jay LILLQUIST

Jay LILLQUIST has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-ALK antibodies and methods for use thereof
    Patent number: 11091559
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to ALK, a receptor tyrosine kinase, and modulate the expression and/or activity of ALK. Also provided are uses and methods for treating, e.g., managing, disorders, such as cancer.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: August 17, 2021
    Assignee: Celldex Therapeutics, Inc.
    Inventors: Diego Alvarado, Jay Lillquist, Gwenda Ligon, Michael Feldhaus
  • Anti-ALK Antibodies and Methods for Use Thereof
    Publication number: 20200157236
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to ALK, a receptor tyrosine kinase, and modulate the expression and/or activity of ALK. Also provided are uses and methods for treating, e.g., managing, disorders, such as cancer.
    Type: Application
    Filed: August 26, 2016
    Publication date: May 21, 2020
    Applicant: Celldex Therapeutics, Inc.
    Inventors: Diego ALVARADO, Jay LILLQUIST, Qwenda LIGON, Michael FELDHAUS